
Tiansheng
002872.SZTiansheng Pharmaceutical Group Co., Ltd. Price (002872.SZ)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
318,000,000
(0)%
Cash Flow Statement
Tiansheng Pharmaceutical Group Co., Ltd.Currency: CNY
YEAR | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||||||
Net Income | 113.20M
+0% |
133.03M
+18% |
173.87M
+31% |
201.30M
+16% |
234.04M
+16% |
255.81M
+9% |
117.51M
-54% |
-218,939,077.46
-286% |
-493,585,115.96
+125% |
-72,339,174.37
-85% |
-91,553,247.62
+27% |
-93,712,531.78
+2% |
|||||||
Depreciation And Amortiz... | 34.74M | 49.33M | 59.82M | 65.66M | 74.05M | 94.71M | 108.50M | 106.06M | 117.05M | 89.99M | 107.72M | 107.26M | |||||||
Deferred Income Tax | 0.00 | 0.00 | 0.00 | 1.75M | -5,015,100.00 | -9,214,707.00 | -596,765.00 | -12,912,814.00 | -44,453,601.00 | 30.38M | 4.24M | -1,401,222.00 | |||||||
Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
Change In Working Capital | |||||||||||||||||||
Accounts Receivables | -38,270,700.00 | -171,234.00 | 9.06k | -156,399,900.00 | 1.35M | -269,525,039.00 | 81.35M | 35.02M | 277.36M | -419,086,140.00 | 54.68M | 103.03M | |||||||
Accounts Payables | 0.00 | 0.00 | 0.00 | 47.85M | 84.68M | -77,436,286.00 | -183,770,467.00 | -23,476,108.00 | -112,931,898.00 | 187.80M | -4,713,805.00 | -231,097,518.00 | |||||||
Inventory | -53,902,400.00 | -166,571,200.00 | -24,320,981.81 | -14,809,579.17 | 53.49M | -95,125,491.63 | 47.99M | 128.77M | -3,686,353.88 | 167.57M | -6,862,456.19 | 49.47M | |||||||
Other Working Capital | 32.14M | -3,361,700.00 | -66,553,662.07 | -106,792,933.58 | 81.02M | -385,756,588.29 | -198,745,520.16 | -12,155,239.00 | -44,453,602.12 | 30.38M | 4.24M | 2.16M | |||||||
Other Non-Cash Items | 18.87M | 44.63M | 49.17M | 68.19M | 64.08M | 74.61M | 78.73M | 128.92M | 450.00M | 34.65M | 25.67M | 39.73M | |||||||
Net Cash Provided By Op... | 145.06M
+0% |
57.06M
-61% |
191.99M
+236% |
213.54M
+11% |
506.68M
+137% |
-55,748,598.61
-111% |
153.99M
-376% |
144.21M
-6% |
189.75M
+32% |
18.97M
-90% |
89.18M
+370% |
-24,561,761.00
-128% |
|||||||
Investing Activities | |||||||||||||||||||
Investments In Propert... | -184,630,300.54 | -126,344,598.53 | -330,322,143.35 | -274,873,630.99 | -425,958,701.82 | -862,247,473.47 | -234,268,942.42 | -93,239,243.74 | -92,700,145.53 | -114,382,593.68 | -73,421,467.88 | -76,737,868.00 | |||||||
Acquisitions Net | 650.38k | -8,495,979.67 | -46,968,000.04 | 166.19k | 63.27k | -4,301,953.39 | -39,234,778.46 | 3.54M | 7.10M | 31.08M | 22.45M | 15.05M | |||||||
Purchases Of Investments | -20,320,181.45 | -5,000,000.00 | -100,000.00 | -6,750,000.00 | 0.00 | -401,000,000.00 | -100,000,000.00 | -142,500,000.00 | -202,070,000.00 | -152,700,000.00 | -188,000,000.00 | -330,000,000.00 | |||||||
Sales Maturities Of Inve... | 84.00k | 14.79M | 214.08k | 120.00k | 120.00k | 303.33M | 201.22M | 102.49M | 201.31M | 398.64M | 271.83M | 330.00M | |||||||
Other Investing Activities | 52.18M | -59,045,581.03 | 16.26M | 26.00M | 31.73M | 10.03M | 11.39M | 1.15M | 10.21M | 6.94M | -98,423,400.39 | -20,395,772.00 | |||||||
Net Cash Used For Inv... | -152,038,831.55
+0% |
-184,098,549.05
+21% |
-360,914,049.67
+96% |
-255,334,331.25
-29% |
-394,108,433.82
+54% |
-954,189,583.07
+142% |
-160,898,870.33
-83% |
-128,561,985.95
-20% |
-76,149,757.19
-41% |
169.58M
-323% |
-65,566,627.27
-139% |
-82,080,013.00
+25% |
|||||||
Financing Activities | |||||||||||||||||||
Debt Repayment | 124.04M | 197.79M | 19.90M | 109.44M | 140.20M | 160.30M | -164,520,000.00 | -63,947,624.00 | -136,040,000.00 | -132,710,000.00 | -66,532,613.00 | 4.73M | |||||||
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
Dividends Paid | -19,399,231.08 | -29,550,312.58 | -37,236,968.86 | -31,097,174.66 | -35,982,515.68 | -34,340,467.98 | -93,013,390.30 | -34,748,928.00 | -37,189,546.00 | -22,894,520.00 | -15,938,839.88 | -15,537,053.00 | |||||||
Other Financing Activities | -63,733,430.92 | -610,844.00 | 203.91M | 1.30M | -35,632,291.00 | 1.11B | -16,077,298.00 | 64.91M | 38.66M | 16.63M | 38.00M | -396,456.00 | |||||||
Net Cash Used/Provide... | 40.90M
+0% |
167.63M
+310% |
186.57M
+11% |
79.65M
-57% |
68.59M
-14% |
1.23B
+1,698% |
-273,610,687.97
-122% |
-33,790,020.35
-88% |
-134,571,476.36
+298% |
-138,969,671.31
+3% |
-44,471,453.35
-68% |
-11,203,509.00
-75% |
|||||||
Effect Of Forex Changes... | 3.26 | 48.38 | 0.00 | 0.00 | 118.46k | -125,364.89 | -130,845.21 | 23.59k | 0.53 | 0.31 | 0.94 | 0.00 | |||||||
Net Change In Cash | 33.92M | 40.59M | 17.64M | 37.85M | 181.27M | 222.93M | -280,653,716.00 | -18,120,132.00 | -20,966,904.00 | 49.58M | -20,853,273.00 | -117,845,275.00 | |||||||
Cash At Beginning Of Per... | 33.71M | 67.63M | 108.22M | 125.86M | 163.71M | 344.98M | 567.97M | 287.32M | 270.49M | 249.52M | 299.10M | 278.25M | |||||||
Cash At End Of Period | 67.63M | 108.22M | 125.86M | 163.71M | 344.98M | 567.91M | 287.32M | 269.20M | 249.52M | 299.10M | 278.25M | 160.41M | |||||||
Additional Metrics: | |||||||||||||||||||
Operating Cash Flow | 145.06M | 57.06M | 191.99M | 213.54M | 506.68M | -55,748,598.61 | 153.99M | 144.21M | 189.75M | 18.97M | 89.18M | -24,561,761.00 | |||||||
Capital Expenditure | -184,630,300.54 | -126,344,598.53 | -330,322,143.35 | -274,873,630.99 | -425,958,701.82 | -862,247,473.47 | -234,268,942.42 | -93,239,243.74 | -92,700,145.53 | -114,382,593.68 | -73,421,467.88 | -76,737,872.00 | |||||||
Free Cash Flow | -39,573,200.54
+0% |
-69,285,298.53
+75% |
-138,333,433.35
+100% |
-61,334,768.99
-56% |
80.72M
-232% |
-917,996,072.08
-1,237% |
-80,282,255.42
-91% |
50.97M
-163% |
97.05M
+90% |
-95,410,801.68
-198% |
15.76M
-117% |
-101,299,622.19
-743% |